Chelation Therapy for Autism: An Unproven, Sometimes Fatal "Cure" That Regulators Won't Touch
In brief: Chelation therapy removes heavy metals from the blood and is approved for treating acute heavy metal poisoning. It has no approved use for autism, rests on a debunked theory linking autism to mercury exposure from vaccines, has never been shown to help in the one controlled trial that has tested it, and has caused documented serious harm — including at least one child's death. It nonetheless remains available to families of autistic children across North America and Europe.
This isn't just fringe opinion — major pediatric bodies say so on the record
American Academy of Pediatrics (United States)
Its official clinical practice guideline, "Identification, Evaluation, and Management of Children With Autism Spectrum Disorder" (Pediatrics, January 2020), formally cautions against chelation therapy due to ineffectiveness and risk of harm, and calls for shared decision-making with parents when they raise it.Zwaigenbaum L, et al. Pediatrics. 2020;145(1). Also see AAP News, Aug 2001: Shannon M, Levy SE, Sandler A, "Chelation therapy neither safe nor effective as autism treatment."
Canadian Paediatric Society
"Therapies that are considered risky and ineffective include hyperbaric oxygen therapy, chelation, secretin, and the use of certain herbal products."CPS Position Statement, "Post-diagnostic management and follow-up care for autism spectrum disorder," October 24, 2019. Developmental pediatrician Lonnie Zwaigenbaum reiterated the warning directly to CBC News that same month, calling chelation "risky."
Royal College of Paediatrics and Child Health (United Kingdom)
"Question 2: Does heavy metal chelation therapy improve the symptoms of autism spectrum disorder?" — answer: no supporting evidence found.Lagan NC, Balfe J. Archives of Disease in Childhood (the RCPCH's own journal). 2018;103(9):910-911.
Where the theory comes from
- The rationale for chelating autistic children rests on the idea that autism is caused or worsened by heavy metal toxicity — historically tied to thimerosal, a mercury-containing preservative once used in some childhood vaccines.
- The vaccine/thimerosal-autism link has been thoroughly disproven in the scientific literature.
- Chelation itself is legitimate and FDA/Health Canada-approved for acute heavy metal poisoning; its use for autism is entirely off-label and untested by that standard.
What the evidence actually shows
- A 2015 systematic review identified only 10 studies of chelation therapy for autism spectrum disorder. Nine were uncontrolled and therefore uninformative as evidence of efficacy.
- The single controlled trial found no benefit. Its authors concluded there was no clinical trial evidence that pharmaceutical chelation is an effective intervention for autism spectrum disorder, and that — given prior reports of serious adverse events including hypocalcaemia, renal impairment, and death — the risks of chelation for autism currently outweigh any proven benefit.
- A 2006 BMJ letter (Sinha, Silove & Williams, Sydney Children's Hospital) reached the same conclusion after a Medline/Premedline search through April 2006 turned up no relevant reviews or randomised controlled trials supporting the practice.
Documented harm
- In 2005, 5-year-old British autistic boy Abubakar Tariq Nadama died of cardiac arrest during his third chelation session at a Pennsylvania clinic, after being given the wrong formulation of the chelating drug (disodium EDTA instead of calcium-EDTA), administered incorrectly. See the full case: Dr. Roy Kerry.
- Practitioners have been documented using unapproved chelation agents and unlicensed routes of administration — including rectal and transdermal delivery — on autistic children, with oral succimer (DMSA) the most common agent.
- A 2013 study estimated roughly half a million children are subjected to chelation for autism in the United States each year; the practice is also common in Canada and Europe.
Why regulators haven't stopped it
- In jurisdictions like Ontario, physicians cannot be found guilty of professional misconduct solely for practicing a therapy that is "non-traditional" or departs from prevailing medical practice — a protection built into the Medicine Act, 1991.
- College policy in Ontario asks only whether a physician followed a defensible process (clinical assessment, informed consent, risk-benefit reasoning) — not whether the treatment itself has scientific support.
- The practical effect: colleges can act only after a specific patient is demonstrably harmed by a specific act — not on the basis that an entire therapy lacks evidence. See the case study: Dr. John Gannage, a Markham, Ontario physician who has offered chelation for autism since 1999 and was cleared by both the CPSO and Ontario's appeal board after a formal complaint.
- Steven Novella, MD (Science-Based Medicine) has argued this amounts to the erosion of any science-based standard of care in medicine, replaced by a "patient autonomy" framework that in practice protects the freedom to sell unproven treatments to vulnerable families.
General resource: If you have a concern about the care or conduct of a physician in Ontario, you can raise it with the College of Physicians and Surgeons of Ontario through its Complaints and Concerns process. Physicians in other jurisdictions are overseen by their own provincial, state, or national medical regulators.
Sources: American Academy of Pediatrics clinical practice guideline (Pediatrics 2020;145(1)) and AAP News (Aug 2001); Canadian Paediatric Society position statement, "Post-diagnostic management and follow-up care for autism spectrum disorder" (Oct 24, 2019); Lagan NC, Balfe J, Archives of Disease in Childhood 2018;103(9):910-911 (RCPCH's journal); Steven Novella, "Chelation Therapy for Autism is Quackery", Science-Based Medicine, September 5, 2018; Sinha Y, Silove N, Williams K, "Chelation therapy and autism," BMJ 2006;333(7571):756, PMC1592402; CBC News reporting on Dr. John Gannage; "Body governing Ontario doctors takes no action against physician offering unproven treatment for autistic children," The Globe and Mail; CDC MMWR review of the Nadama death (2006).